Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 ยป More





| 1 |

 

 
  Tags
 
health plan nicotine depression OnTrak alcoholism naloxone hydrocodone UnitedHealthcare painkillers behavioral healthcare health reform sober SD members drinking mental illness Harold Urschel muscle relaxant relapse prevention behavioral health care Health Care Utilization craving score Co Occurring Disorders psychosocial randomized medical costs over-the-counter substances heroin overdose contract opioid medical opioid-drug interactions cocaine pain killers stimulants alcohol treatment substance dependence drug treatment ER primary care PTSD cocaine treatment alcohol dependence buprenorphine post-traumatic stress disorder treatment behavioral health ADD sugar substance use disorder opioid overdose opioid antagonist health insurance stratified addiction treatment placebo-controlled pain pills reduction in craving data mining meth double-blind identification flumazenil reducing craving suboxone drug addicts behavioral health care services marijuana opiates Research Across America opiod-based gabapentin facebook substance dependence costs urine drug screen opioid abuse alcohol oxycodone drug abuse Catasys predictive modeling depression screening anxiety dependence issues prometa recovery network stress methadone fentanyl Raymond Anton emergency room hospital vicodin narcotic bipolar disorder high-utilizing OxyContin methamphetamine dependence physician- patient relations SD health insurance withdrawal trauma communication addict sobriety vivitrol care coaching Journal of Psychopharmacology Opioid Treatment relapse prescriptions placebo cigarettes drug addiction mental health ADHD CIWA binge drinking alcohol drinking medical and behavioral costs codeine drug use reduction in use smoking behavioral healthcare services hospitalizations recovery craving methamphetamine diabetes percocet morphine social network opiod abuse pain medication Opioid Medications addiction chronic pain substance dependence health insurance
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025